APA (7th ed.) Citation

Yue Zhang, Faliang Ren, Bing Ni, Tao Jing, & Jun Tang. (2021). Tumor targeting nanoparticle E749-57-HSP110-RGD elicits potent anti-tumor immune response in a CD8-dependent manner in cervical cancer-bearing mouse model. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Yue Zhang, Faliang Ren, Bing Ni, Tao Jing, and Jun Tang. Tumor Targeting Nanoparticle E749-57-HSP110-RGD Elicits Potent Anti-tumor Immune Response in a CD8-dependent Manner in Cervical Cancer-bearing Mouse Model. Taylor & Francis Group, 2021.

MLA (9th ed.) Citation

Yue Zhang, et al. Tumor Targeting Nanoparticle E749-57-HSP110-RGD Elicits Potent Anti-tumor Immune Response in a CD8-dependent Manner in Cervical Cancer-bearing Mouse Model. Taylor & Francis Group, 2021.